E Tricamo

1.7k total citations
30 papers, 1.3k citations indexed

About

E Tricamo is a scholar working on Pharmacology, Cognitive Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, E Tricamo has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 9 papers in Cognitive Neuroscience and 9 papers in Psychiatry and Mental health. Recurrent topics in E Tricamo's work include Treatment of Major Depression (19 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers) and Electroconvulsive Therapy Studies (6 papers). E Tricamo is often cited by papers focused on Treatment of Major Depression (19 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers) and Electroconvulsive Therapy Studies (6 papers). E Tricamo collaborates with scholars based in United States, Germany and Canada. E Tricamo's co-authors include Judith G. Rabkin, Jonathan W. Stewart, Wilma Harrison, Patrick J. McGrath, Frederic M. Quitkin, Katja Ocepek‐Welikson, Patrick J. McGrath, F M Quitkin, D F Klein and Edward V. Nunes and has published in prestigious journals such as American Journal of Psychiatry, The British Journal of Psychiatry and Psychiatry Research.

In The Last Decade

E Tricamo

30 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Tricamo United States 19 776 612 420 256 212 30 1.3k
Ram Shrivastava United States 16 554 0.7× 577 0.9× 443 1.1× 172 0.7× 174 0.8× 28 1.3k
Arnd Barocka Germany 17 603 0.8× 425 0.7× 531 1.3× 224 0.9× 386 1.8× 34 1.5k
James L. Claghorn United States 21 506 0.7× 831 1.4× 355 0.8× 476 1.9× 362 1.7× 70 1.7k
F M Quitkin United States 24 935 1.2× 814 1.3× 565 1.3× 313 1.2× 452 2.1× 43 2.0k
Peter D. Londborg United States 14 496 0.6× 344 0.6× 599 1.4× 423 1.7× 217 1.0× 19 1.2k
O. Jacobsen Denmark 7 536 0.7× 375 0.6× 453 1.1× 162 0.6× 187 0.9× 9 1.0k
Frederick Quitkin United States 7 702 0.9× 509 0.8× 223 0.5× 109 0.4× 101 0.5× 8 1.1k
J M Perel United States 21 331 0.4× 433 0.7× 263 0.6× 450 1.8× 195 0.9× 31 1.3k
Wolfram Bender Germany 16 418 0.5× 408 0.7× 256 0.6× 220 0.9× 172 0.8× 30 952
Ion Anghelescu Germany 21 360 0.5× 557 0.9× 225 0.5× 320 1.3× 235 1.1× 54 1.6k

Countries citing papers authored by E Tricamo

Since Specialization
Citations

This map shows the geographic impact of E Tricamo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Tricamo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Tricamo more than expected).

Fields of papers citing papers by E Tricamo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Tricamo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Tricamo. The network helps show where E Tricamo may publish in the future.

Co-authorship network of co-authors of E Tricamo

This figure shows the co-authorship network connecting the top 25 collaborators of E Tricamo. A scholar is included among the top collaborators of E Tricamo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Tricamo. E Tricamo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stewart, Jonathan W., et al.. (1997). Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission. American Journal of Psychiatry. 154(1). 31–36. 55 indexed citations
2.
Quitkin, Frederic M., et al.. (1994). A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives. International Journal of Eating Disorders. 15(1). 1–9. 38 indexed citations
3.
Donovan, Stephen J., Frederic M. Quitkin, Jonathan W. Stewart, et al.. (1994). Duration of Antidepressant Trials. Journal of Clinical Psychopharmacology. 14(1). 64???66–64???66. 18 indexed citations
4.
Stewart, J W, et al.. (1993). Chronic depression: response to placebo, imipramine, and phenelzine.. PubMed. 13(6). 391–6. 30 indexed citations
5.
Quitkin, Frederic M., Jonathan W. Stewart, Patrick J. McGrath, et al.. (1993). Further Evidence That a Placebo Response to Antidepressants Can Be Identified. Survey of Anesthesiology. 39(6). 342–342. 7 indexed citations
6.
Quitkin, F M, Jonathan W. Stewart, Patrick J. McGrath, et al.. (1993). Loss of drug effects during continuation therapy. American Journal of Psychiatry. 150(4). 562–565. 30 indexed citations
7.
Quitkin, F M, Jonathan W. Stewart, Patrick J. McGrath, et al.. (1993). Columbia Atypical Depression. The British Journal of Psychiatry. 163(S21). 30–34. 130 indexed citations
8.
McGrath, Patrick J., Jonathan W. Stewart, Wilma Harrison, et al.. (1992). Predictive Value of Symptoms of Atypical Depression. Journal of Clinical Psychopharmacology. 12(3). 197???202–197???202. 50 indexed citations
9.
Quitkin, Frederic M., Judith G. Rabkin, Patrick J. McGrath, et al.. (1991). Heterogeneity of clinical response during placebo treatment. American Journal of Psychiatry. 148(2). 193–196. 58 indexed citations
10.
Quitkin, Frederic M., Patrick J. McGrath, Judith G. Rabkin, et al.. (1991). Different types of placebo response in patients receiving antidepressants. American Journal of Psychiatry. 148(2). 197–203. 43 indexed citations
11.
Quitkin, F M, Patrick J. McGrath, J W Stewart, et al.. (1989). Phenelzine and Imipramine in Mood Reactive Depressives. Archives of General Psychiatry. 46(9). 787–787. 93 indexed citations
12.
Parsons, Bruce, Frederic M. Quitkin, Patrick J. McGrath, et al.. (1989). Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression.. PubMed. 25(4). 524–34. 53 indexed citations
13.
Stewart, Jonathan W., Frederic M. Quitkin, Patrick J. McGrath, et al.. (1988). Social functioning in chronic depression: Effect of 6 weeks of antidepressant treatment. Psychiatry Research. 25(2). 213–222. 75 indexed citations
14.
Wager, Steven, Frederic M. Quitkin, Jonathan W. Stewart, et al.. (1988). Cilobamine in the treatment of atypical depression. Human Psychopharmacology Clinical and Experimental. 3(3). 201–205. 1 indexed citations
15.
Quitkin, F M, Jonathan W. Stewart, Patrick J. McGrath, et al.. (1988). Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders. American Journal of Psychiatry. 145(3). 306–311. 159 indexed citations
16.
McGrath, Patrick J., David K. Blood, Jonathan W. Stewart, et al.. (1987). A Comparative Study of the Electrocardiographic Effects of Phenelzine, Tricyclic Antidepressants, Mianserin, and Placebo. Journal of Clinical Psychopharmacology. 7(5). 335???338–335???338. 9 indexed citations
17.
Stewart, Jeffrey, et al.. (1987). Validity assessment of SAFTEE: a preliminary report.. PubMed. 23(1). 102–5. 7 indexed citations
18.
McGrath, Patrick J., et al.. (1985). Phenelzine versus imipramine in atypical depression. Journal of Clinical Psychopharmacology. 5(1). 56–56. 15 indexed citations
19.
McGrath, Patrick J., et al.. (1985). Effect of panic attacks on the treatment of atypical depressives.. PubMed. 21(3). 558–61. 10 indexed citations
20.
Rabkin, Judith G., Frederic M. Quitkin, Wilma Harrison, E Tricamo, & Patrick J. McGrath. (1984). Adverse Reactions to Monoamine Oxidase Inhibitors. Part I. A Comparative Study. Journal of Clinical Psychopharmacology. 4(5). 270???278–270???278. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ram Shrivastava Breakdown of academic impact, for papers by Arnd Barocka Breakdown of academic impact, for papers by James L. Claghorn Breakdown of academic impact, for papers by F M Quitkin Breakdown of academic impact, for papers by Peter D. Londborg Breakdown of academic impact, for papers by O. Jacobsen Breakdown of academic impact, for papers by Frederick Quitkin Breakdown of academic impact, for papers by J M Perel Breakdown of academic impact, for papers by Wolfram Bender Breakdown of academic impact, for papers by Ion Anghelescu
Rankless by CCL
2026